1) CRM Shared Resource (CRM - Section 9.1.7): CRM is responsible for all centralized oversight andcoordination of protocol and data management activities of CCCWFU clinical research. CRM providescentralized patient registration, patient eligibility confirmation, drug monitoring and informatics services.CRM also provides operational and logistical oversight for the Protocol Review and Monitoring System(PRMS), Protocol Specific Research Support (PSRS) and Data and Safety Monitoring functions (DSM),ensuring alignment with CCCWFU scientific strategy and adherence to regulatory mandates. CRMprovides quality control oversight of data management, providing investigators assurance of high quality,efficient data management by trained and supervised staff.2) Protocol Review and Monitoring System (PRMS - Section 9.2): PRMS supports protocol developmentand protocol monitoring. PRMS evaluates all protocols for scientific merit and prioritizes protocolsbased on explicit CCCWFU priorities. PRMS also provides investigators with guidance in protocol writingand compliance with NCI and FDA regulatory guidelines. PRMS facilitates communications amongCCCWFU members, nurses, and staff, as well as with affiliate physicians and staff.3) Protocol Specific Research Support (PSRS Section 9.3): The PSRS functions include patientrecruitment, screening, compliance monitoring, and data management for institutional investigatorinitiatedCCCWFU feasibility and Phase I trials.4) Data and Safety Monitoring (DSM - Section 12.0): DSM identifies issues related to safety before andduring the course of studies. DSM reviews data trends related to safety and protocol milestones thatmight require protocol suspension or termination. Two committees in oversight of DSM functions, onefor phase I and II studies, and a separate committee for phase III studies. Support for these DSMfunctions is provided through personnel in the CRM shared resource. The CCCWFU has an NCIapprovedDSM plan.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA012197-32
Application #
7529769
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-07-11
Project End
2012-01-31
Budget Start
2007-07-11
Budget End
2008-01-31
Support Year
32
Fiscal Year
2007
Total Cost
$102,202
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Yang, M; Forbes, M E; Bitting, R L et al. (2018) Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system? Ann Oncol 29:311-323
Godwin, Ryan C; Gmeiner, William H; Salsbury Jr, Freddie R (2018) All-atom molecular dynamics comparison of disease-associated zinc fingers. J Biomol Struct Dyn 36:2581-2594
Votanopoulos, Konstantinos Ioannis; Bartlett, David; Moran, Brendan et al. (2018) PCI is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries. Ann Surg Oncol 25:674-678
Lamar, Zanetta S; Dothard, Andrew; Kennedy, LeAnne et al. (2018) Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study. Leuk Lymphoma 59:1871-1877
Melvin, Ryan L; Xiao, Jiajie; Berenhaut, Kenneth S et al. (2018) Using correlated motions to determine sufficient sampling times for molecular dynamics. Phys Rev E 98:023307
Bhatt, Nikunj B; Pandya, Darpan N; Dezarn, William A et al. (2018) Practical Guidelines for Cerenkov Luminescence Imaging with Clinically Relevant Isotopes. Methods Mol Biol 1790:197-208
Gesell, Sabina B; Golden, Shannon L; Limkakeng Jr, Alexander T et al. (2018) Implementation of the HEART Pathway: Using the Consolidated Framework for Implementation Research. Crit Pathw Cardiol 17:191-200
Mao, Chengqiong; Qu, Ping; Miley, Michael J et al. (2018) P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates. Biomater Sci 6:3063-3074
Bhatt, Nikunj B; Pandya, Darpan N; Rideout-Danner, Stephanie et al. (2018) A comprehensively revised strategy that improves the specific activity and long-term stability of clinically relevant 89Zr-immuno-PET agents. Dalton Trans 47:13214-13221
Andrews, Rachel N; Caudell, David L; Metheny-Barlow, Linda J et al. (2018) Fibronectin Produced by Cerebral Endothelial and Vascular Smooth Muscle Cells Contributes to Perivascular Extracellular Matrix in Late-Delayed Radiation-Induced Brain Injury. Radiat Res 190:361-373

Showing the most recent 10 out of 548 publications